Please assess the completion status of the following clinical trial:

Trial Title: MiDAS II (Mild® Decompression Alternative to Open Surgery): Vertos Mild Patient Evaluation Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic lumbar spinal stenosis (LSS) primarily caused by dorsal element hypertrophy.~* Prior failure of conservative therapy and Oswestry Disability Index (ODI) score \> 20%.~* Radiologic evidence of lumbar spinal stenosis (LSS), ligamentum flavum hypertrophy (typically \> 2.5 mm), confirmed by pre-op MRI and/or CT.~* Central canal cross sectional area clearly reduced per MRI/CT report.~* If present, anterior listhesis preferred ≤ 5.0mm and deemed stable by Investigator.~* Able to walk at least 10 feet unaided before being limited by pain.~* Available to complete 26 weeks of follow-up.~* A signed Informed Consent Form is obtained from the patient.~* Adults at least 18 years of age.~Exclusion Criteria:~* Prior surgery at intended treatment level.~* Compound fracture with interspinal retropulsion contributing to spinal stenosis.~* Disabling back or leg pain from causes other than LSS (e.g. acute compression fracture, metabolic neuropathy, or vascular claudication symptoms, etc.).~* Disc protrusion or osteophyte formation severe enough to confound study outcome.~* Facet hypertrophy severe enough to confound study outcome.~* Bleeding disorders and/or current use of anti-coagulants.~* Use of acetylsalicylic acid (ASA) and/or non-steroidal anti-inflammatory drug (NSAID) within 5 days of treatment.~* Epidural steroid administration within prior three weeks (of procedure).~* Inability of the patient to lie prone for any reason with anesthesia support (e.g.chronic obstructive pulmonary disease (COPD), obesity, etc.).~* Metabolic wound healing pathologies deemed by Investigator to compromise study outcomes.~* Dementia and/or inability to give informed consent.~* Pregnant and/or breastfeeding.~* On Workman's Compensation or considering litigation associated with back pain.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- lumbar decompression (Type: OTHER): Percutaneous lumbar decompression with mild® Device Kit.

Based on this trial design, predict the completion outcome and termination type (if applicable).